|
| 34542553 | Effectiveness and Ethics of Incentives for Research Participation: 2 Randomized Clinical Trials. | JAMA Intern Med | 2021 |
| 31306800 | Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries. | Clin Gastroenterol Hepatol | 2020 |
| 33447520 | Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B. | J Clin Transl Hepatol | 2020 |
| 32227179 | Effect of Default Options in Advance Directives on Hospital-Free Days and Care Choices Among Seriously Ill Patients: A Randomized Clinical Trial. | JAMA Netw Open | 2020 |
| 30681717 | Intuitive vs Deliberative Approaches to Making Decisions About Life Support: A Randomized Clinical Trial. | JAMA Netw Open | 2019 |
| 31236182 | Small Cell Lung Cancer Invading the Left Atrium With Subsequent Malignant Embolic Stroke: A Case Report and Review of Literature. | Cardiol Res | 2019 |
| 31431933 | A pilot randomized trial of five financial incentive strategies to increase study enrollment and retention rates. | Contemp Clin Trials Commun | 2019 |
| 29159444 | Are Demographic Characteristics Associated with Advance Directive Completion? A Secondary Analysis of Two Randomized Trials. | J Gen Intern Med | 2018 |
| 30288436 | Active Choice Intervention Increases Advance Directive Completion: A Randomized Trial. | MDM Policy Pract | 2018 |
| 30385535 | Contributors to Intensive Care Unit Clinicians' Predictions of Patient Outcomes: A Qualitative Analysis. | Am J Crit Care | 2018 |
| 27510741 | A Randomized Trial of Expanding Choice Sets to Motivate Advance Directive Completion. | Med Decis Making | 2017 |
| 28622004 | Six-Month Morbidity and Mortality among Intensive Care Unit Patients Receiving Life-Sustaining Therapy. A Prospective Cohort Study. | Ann Am Thorac Soc | 2017 |
| 28528347 | Discriminative Accuracy of Physician and Nurse Predictions for Survival and Functional Outcomes 6 Months After an ICU Admission. | JAMA | 2017 |
| 28611778 | Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients. | Front Immunol | 2017 |
| 28679811 | Approximately One In Three US Adults Completes Any Type Of Advance Directive For End-Of-Life Care. | Health Aff (Millwood) | 2017 |
| 27252235 | Public Opinion Regarding Financial Incentives to Engage in Advance Care Planning and Complete Advance Directives. | Am J Hosp Palliat Care | 2017 |
| 26739688 | Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B). | J Hepatol | 2016 |
| 27423688 | No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals. | Trials | 2016 |
| 27266769 | Default options in advance directives: study protocol for a randomised clinical trial. | BMJ Open | 2016 |
| 27348271 | Rationale and Design of the Randomized Evaluation of Default Access to Palliative Services (REDAPS) Trial. | Ann Am Thorac Soc | 2016 |
| 27339614 | Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin. | Haemophilia | 2016 |
| 25311593 | Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection. | Gastroenterology | 2015 |
| 26039807 | Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-λ-1a and PEG-IFN-α2a in naive patients. | Bioanalysis | 2015 |
| 26035147 | An Observational Study of Decision Making by Medical Intensivists. | Crit Care Med | 2015 |
| 25496007 | A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1. | J Viral Hepat | 2015 |
| 24575984 | Objective factors associated with physicians' and nurses' perceptions of intensive care unit capacity strain. | Ann Am Thorac Soc | 2014 |
| 24786714 | Outcomes and statistical power in adult critical care randomized trials. | Am J Respir Crit Care Med | 2014 |
| 23535589 | Do windows or natural views affect outcomes or costs among patients in ICUs? | Crit Care Med | 2013 |
| 23688301 | A randomized trial of nighttime physician staffing in an intensive care unit. | N Engl J Med | 2013 |
| 23381535 | Default options in advance directives influence how patients set goals for end-of-life care. | Health Aff (Millwood) | 2013 |
| 21174498 | CHAT: development and validation of a computer-delivered, self-report, substance use assessment for adolescents. | Subst Use Misuse | 2011 |
| 21660812 | A survey of 100 community colleges on student substance use, programming, and collaborations. | J Am Coll Health | 2011 |
| 21503940 | Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study. | Hepatology | 2011 |
| 18708171 | Cost of growth and maintenance in chicken embryos during normoxic or hypoxic conditions. | Respir Physiol Neurobiol | 2008 |
| 12522766 | Cerebellar brain abscess associated with tongue piercing. | Clin Infect Dis | 2003 |
| 11740712 | Clinical indicators of immune restoration following highly active antiretroviral therapy. | Clin Infect Dis | 2002 |
| 11530066 | Progressive outer retinal necrosis and acute retinal necrosis in fellow eyes of a patient with acquired immunodeficiency syndrome. | Am J Ophthalmol | 2001 |
| 11922185 | Esophageal actinomycosis in a patient with AIDS. | Yale J Biol Med | 2001 |
| 11491415 | Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults. | Antivir Ther | 2001 |
| 11125881 | Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. | AIDS | 2000 |
| 11023459 | Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214. | J Infect Dis | 2000 |
| 9878037 | Interleukin-12 enhancement of antigen-specific lymphocyte proliferation correlates with stage of human immunodeficiency virus infection. | J Infect Dis | 1999 |
| 10371177 | Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone. | AIDS | 1999 |
| 9776425 | Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria. | Clin Nephrol | 1998 |
| 9455526 | Review of pneumococcal endocarditis in adults in the penicillin era. | Clin Infect Dis | 1998 |
| 9597276 | Clostridium difficile colitis: a possible cause of unexplained elevation of serum alkaline phosphatase levels in patients with AIDS. | Clin Infect Dis | 1998 |
| 9499777 | Varicella zoster virus retrobulbar optic neuritis preceding retinitis in patients with acquired immune deficiency syndrome. | Ophthalmology | 1998 |
| 9675471 | Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: case report and review. | Clin Infect Dis | 1998 |
| 9114223 | Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS. | Clin Infect Dis | 1997 |
| 8898668 | A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team. | J Acquir Immune Defic Syndr Hum Retrovirol | 1996 |